William Jacobs, – microbiology and immunology and molecular genetics at Einstein and Howard Hughes Medical Institute. ‘urgently need urgently need to develop new and more effective anti-TB drugs. ‘.. One of the chemicals has been found to be four times more lethal than isoniazid against the bacteria, while the other is shown times more potent times more potent. These chemically similar seem appear to harm higher organisms, so they could probably be used against TB bacteria without risk to patients. – ‘-Drug resistant Mycobacterium tuberculosis is a worldwide problem, especially in people with compromised immune systems, such as infected with HIV,’says senior author Dr.
The study by Han Jing – Yan et al Ginsenosaide Rb1 discovered in a position to prevent hepatic microcirculatory disturbance and subsequent liver injury in mice by intestinal ischemia and reperfusion induced. R1 is one of the main active ingredients of Panax notoginseng , a traditional Chinese herbal medicine often included in various compound Chinese medicine for the treatment of liver disease and many other diseases in China and other Asian countries.Told Karen Strategic Health Authorities – idofact Reaction, UKcommented on notification by Minister of Health Andrew Lansley to Strategic Health Authorities will be to be scrapped out of April 2012, said Karen Jennings, idofact Head Game of Health:.